t.abubakar

TL2 · Plovdiv

Contributes reviews on supplier material. Based in Plovdiv.

Joined 3 May 2025 · last posted 2d

74 posts, newest first. Showing up to 150.

Trust level 3 requirements: a clarification — does this still hold? Replied, post #90 · Meta › Announcements · 26 Jul 2026 · 26 likes Noted, and I have changed what I was going to do on the strength of it.
Follow-up: Reading an interaction checker output critically Replied, post #66 · Practice › Interactions · 26 Jul 2026 · 0 likes Offering a way to settle Reading an interaction checker output rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the…
Manufacturer assistance programmes and their eligibility rules Replied, post #43 · Access › Pricing · 17 Jul 2026 · 13 likes Picking up post #40: that is the part I would want checked first. I changed my mind about manufacturer assistance programmes after someone here asked me for the source…
What is genuinely unknown about long-term amylin agonism Replied, post #32 · Compounds › Cagrilintide & amylin analogues · 13 Jul 2026 · 0 likes Post #31 is right about the mechanism and I think understates the practical bit. For anyone arriving from searches on "amylin agonist": this subcategory discusses…
The headache that turns out to be dehydration — the long version Replied, post #60 · Nutrition & Training › Hydration & electrolytes · 2 Jul 2026 · 0 likes Adding the measurement that post #58 says would settle it. Since headache keeps coming up, it should probably be a maintained page rather than a recurring thread. I am…
Why we ask for units every single time, with three examples of what goes wrong Replied, post #79 · Start Here › How to Ask · 28 Jun 2026 · 0 likes On post #75 — agreed on the reasoning, with one qualification. Nobody minds being asked to explain a term. The people who use them most are the quickest to define them,…
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #90 · Safety › Contraindications · 28 Jun 2026 · 25 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
Tracking intake honestly when appetite is absent Replied, post #75 · Nutrition & Training › Protein & intake · 27 Jun 2026 · 2 likes Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the gastrointestinal effects of these compounds. High fibre on top of…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #37 · Access › International · 26 Jun 2026 · 14 likes Taking post #36 at face value and following it one step further. Where a jurisdiction has published guidance for clinicians, that document usually answers the practical…
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #14 · Practice › Side effects · 25 Jun 2026 · 1 like Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #34 · Sourcing › Independent verification · 22 Jun 2026 · 0 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
Documenting a supplier's response to a discrepancy Replied, post #18 · Sourcing › Vendor reports · 19 Jun 2026 · 29 likes Adding the measurement that post #15 says would settle it. The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure…
Molecular mass of semaglutide and why the figure differs between sources Replied, post #80 · Compounds › Semaglutide · 17 Jun 2026 · 16 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #2 · Practice › Side effects · 16 Jun 2026 · 19 likes This is the first time the answer has come with its own limits attached. Appreciated.
Second pass at: Absence of evidence and evidence of absence Replied, post #19 · Research Methods › Statistics · 10 Jun 2026 · 2 likes Helpful, and easy to find again, which is half of what a good reply is.
Designing a personal experiment that could change your mind — one year on Replied, post #57 · Research Methods › N-of-1 designs · 7 Jun 2026 · 25 likes Duration should be set by how long an effect would take to appear rather than by patience. Stopping early is the commonest reason a personal experiment answers nothing.
Request: a per-category review queue Replied, post #18 · Meta › Feature requests · 4 Jun 2026 · 0 likes Same experience here, different supplier, so it is at least not unique to one of them.
Reading a trial's population section before its results Replied, post #79 · Evidence › Trials · 2 Jun 2026 · 10 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #109 · Compounds › Tirzepatide · 31 May 2026 · 13 likes Comparisons between the tirzepatide and semaglutide programmes across trials rather than within one are weak. Different populations, different durations, different…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #44 · Practice › Storage & stability · 27 May 2026 · 22 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. The step people skip is the one I have…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #51 · Devices › Syringes & needles · 25 May 2026 · 10 likes Reading the barrel at eye level matters more than any equipment choice. Parallax at a shallow angle is enough to shift a reading by a graduation. Worth checking against…
Reading a trial's population section before its results Replied, post #8 · marked as the solution · Evidence › Trials · 9 May 2026 · 12 likes Everything in post #4 holds. The case it does not cover is the one I have. A treatment-policy estimand asks what happens to people assigned to a strategy, including…
[2026 update] Thyroid function tests during substantial weight change Replied, post #47 · Clinical › Bloodwork · 23 Apr 2026 · 0 likes Where I part company with post #43, and it is a narrow parting. The failure mode on Thyroid function tests during substantial is boring rather than dramatic. It is…
Journal club: is percentage weight change the right endpoint? Replied, post #36 · Evidence › Journal club · 3 Apr 2026 · 1 like Post #35 put the caveat in the right place and I want to underline it. Where the group cannot agree, record the disagreement rather than resolving it by seniority. The…
Coming back to: Time to steady state after a dose increase Replied, post #24 · Pharmacology › Pharmacokinetics · 1 Apr 2026 · 5 likes Picking up post #21: that is the part I would want checked first. A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody…
Stepping down deliberately, and how to do it without losing progress Replied, post #82 · Practice › Dosing & titration · 29 Mar 2026 · 5 likes I came in to disagree and I am leaving without a disagreement.
Choosing which test to pay for, given a fixed budget Replied, post #24 · Sourcing › Independent verification · 14 Mar 2026 · 7 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. That is a description of practice, not a…
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #53 · Compounds › Repair & healing peptides · 13 Mar 2026 · 0 likes Picking up post #52: that is the part I would want checked first. Adding a null result on Reading a preclinical wound-healing model. I looked, carefully, and found…
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #58 · Analytics › Mass spectrometry · 5 Mar 2026 · 31 likes Post #55 is right about the mechanism and I think understates the practical bit. The question underneath Adducts is usually "how would I tell?" rather than "what is…
Named, unnamed and unspecified impurities as regulatory categories Replied, post #8 · Analytics › Impurities & related substances · 28 Feb 2026 · 0 likes Post #7 and I disagree about the size of the effect, not about the direction. The honest reading of a purity figure: it is an upper bound on how much of what the method…
Validating a calculator against hand arithmetic Replied, post #8 · Data & Tools › Calculators · 26 Feb 2026 · 7 likes A calculator that shows its working is worth ten that give an answer. The whole value is being able to see which step you disagree with. I am describing what is, rather…
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #74 · Sourcing › Vendor reports · 25 Feb 2026 · 28 likes I read post #72 twice before replying, because I had assumed the opposite. Photograph the vial and the label before opening. It costs ten seconds and it is what turns a…
Measurement error in a self-reported exposure Replied, post #30 · Evidence › Study critique · 23 Feb 2026 · 10 likes Adding the boring version of measurement error, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #101 · Compounds › Oral incretins · 17 Feb 2026 · 4 likes PIONEER 6 is the cardiovascular outcome trial for oral semaglutide and it enrolled a diabetes population at high cardiovascular risk. Quoting it outside that population…
A history of disordered eating: proceeding carefully Replied, post #71 · Wellbeing › Mental health · 23 Jan 2026 · 2 likes Nothing here is medical advice and several members in this subcategory say plainly that they are describing their own experience only. Scoping that to what I have…
The headache that turns out to be dehydration Replied, post #142 · Nutrition & Training › Hydration & electrolytes · 17 Jan 2026 · 2 likes Two people in this thread mean different things by headache and are disagreeing about the definition while believing they are disagreeing about the facts. Worth pausing…
A partial dose because the pen emptied mid-injection Replied, post #12 · Practice › Administration · 7 Jan 2026 · 2 likes I had written a reply contradicting post #8 and deleted it. Here is what survived. Research-use-only preparations are not supplied with administration instructions…
Prescription requirements and telehealth models Replied, post #46 · Sourcing › Regulatory · 3 Dec 2025 · 4 likes Taking post #43 at face value and following it one step further. A note on scope: what I am saying about prescription requirements and telehealth models applies to the…
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #89 · Practice › Reconstitution · 26 Nov 2025 · 0 likes On post #85 — agreed on the reasoning, with one qualification. A 0.3 mL barrel has more space between graduations than a 1 mL barrel for the same volume, which is the…
New subcategory: rationale and scope Replied, post #19 · Meta › Announcements · 14 Oct 2025 · 0 likes Worth separating two things that post #15 runs together. Thank you for announcing it in advance rather than after. The number of places that do the reverse is remarkable.
Power cut for eleven hours: how I assessed it afterwards Replied, post #82 · Practice › Storage & stability · 4 Oct 2025 · 11 likes I had written a reply contradicting post #78 and deleted it. Here is what survived. Clarity is a weak test. A solution can lose a significant fraction of its active…
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #105 · Evidence › Preprints · 3 Oct 2025 · 0 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.…
Reading a supplier's product description as a marketing document Replied, post #74 · Compounds › Other compounds · 23 Sep 2025 · 24 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
Titles that describe the question, not the situation Replied, post #72 · Start Here › How to Ask · 15 Aug 2025 · 21 likes An observation about titles that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
A preprint whose numbers changed substantially at publication Replied, post #11 · Evidence › Preprints · 6 Aug 2025 · 18 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
AOD-9604 and the fragment hypothesis, revisited Replied, post #7 · Compounds › Other compounds · 5 Aug 2025 · 19 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #22 · Compounds › Repair & healing peptides · 23 Jul 2025 · 8 likes Thank you for the correction. I would rather find out here than later.
Coming back to: Why quantitation is the hard part, not detection Replied, post #36 · Analytics › Home & field testing · 9 Jul 2025 · 0 likes Post #35 is right about the mechanism and I think understates the practical bit. Documenting home checks with dates and lots makes them accumulate into something.…
Holding a dose indefinitely: is there a documented downside? Replied, post #27 · Practice › Dosing & titration · 23 Jun 2025 · 0 likes Narrowing post #26, because the general version has more than one answer. Holding at a dose that is working is a legitimate position and it is not what the trial…
Coming back to: Official shortage notices and what they authorise Replied, post #27 · Access › Shortages · 11 Jun 2025 · 16 likes Official shortage notices: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
Anxiety in the first weeks: drug, situation, or both Replied, post #100 · Wellbeing › Mental health · 9 Jun 2025 · 6 likes The arithmetic in post #99 is right; the assumption feeding it is the part to check. A methods point on anxiety rather than a substantive one: if the comparison is not…
Pre-registering a personal experiment, seriously Replied, post #78 · Research Methods › N-of-1 designs · 1 Jun 2025 · 1 like Worth separating two things that post #76 runs together. Nothing in a personal experiment is medical advice to anyone including yourself, and several people here have…
Validating a calculator against hand arithmetic — what changed since Replied, post #59 · Data & Tools › Calculators · 9 May 2025 · 8 likes Do the arithmetic by hand the first few times, whatever tool you use afterwards. A calculator with a wrong input gives a confident wrong answer and there is nothing in…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #51 · Compounds › Tirzepatide · 8 May 2025 · 0 likes Taking post #48 at face value and following it one step further. Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical…
Washout: how long is long enough, and for what purpose Replied, post #20 · Pharmacology › Pharmacokinetics · 23 Apr 2025 · 0 likes Offering a way to settle washout rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the noise,…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #70 · Evidence › Journal club · 20 Apr 2025 · 11 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
[2026 update] US compounding rules and how they changed Replied, post #7 · Regional › North America · 7 Apr 2025 · 5 likes Worth separating two things that post #5 runs together. Formulary position changes on a schedule that is published in advance, which means a decision made now may be…
Reading a supplier's product description as a marketing document Replied, post #10 · Compounds › Other compounds · 5 Apr 2025 · 9 likes Answering the question post #8 raises rather than the one it answers. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature,…
Counter-ion form: the field almost nobody reports — one year on Replied, post #76 · Analytics › COA interpretation · 13 Mar 2025 · 18 likes Adding a data point of agreement rather than a data point.
Second pass at: A single out-of-range value on an otherwise normal panel Replied, post #10 · Clinical › Bloodwork · 12 Mar 2025 · 0 likes Keeping your own results in a single table with dates is more useful than any individual result in it, and almost nobody starts early enough. Two sources, same…
Distinguishing a deletion sequence by mass alone Replied, post #94 · Analytics › Mass spectrometry · 16 Feb 2025 · 1 like The number people quote for distinguishing a deletion sequence is a central estimate presented without its interval, and the interval is wide enough that the estimate…
Books and papers worth reading that are not about this at all Replied, post #17 · Lounge › Off topic · 9 Jan 2025 · 5 likes Thank you for the correction. I would rather find out here than later.
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #100 · Compounds › Oral incretins · 28 Dec 2024 · 24 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
Building a sensible monitoring schedule with your prescriber Replied, post #45 · Clinical › Bloodwork · 20 Dec 2024 · 8 likes I would call the community position on building a sensible monitoring schedule likely rather than established, and I would be comfortable defending that hedge.
[2026 update] How to read a forest plot, properly, from scratch Replied, post #19 · Evidence › Trials · 6 Dec 2024 · 2 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
[2026 update] New subcategory: rationale and scope Replied, post #26 · Meta › Announcements · 27 Nov 2024 · 12 likes I would call the community position on New subcategory likely rather than established, and I would be comfortable defending that hedge.
Research-use-only labelling: what it means and what it does not — the long version Replied, post #16 · Sourcing › Regulatory · 25 Oct 2024 · 0 likes Summarising the Research-use-only labelling thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to…
Requesting a page: what makes a good request — what changed since Replied, post #36 · Documentation › Wiki requests · 10 Oct 2024 · 4 likes Taking post #35 at face value and following it one step further. Objections to a request belong in the open, and a request that survives an objection is a stronger page…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #53 · Clinical › Bloodwork · 24 Sep 2024 · 1 like That is a cleaner way of putting what I was circling around.
Progressive overload when the scale is falling — one year on Replied, post #72 · Nutrition & Training › Resistance training · 20 Sep 2024 · 0 likes Cardiovascular work has its own benefits and is not a substitute for a resistance stimulus for this particular purpose. Someone should write this up properly, and it…
About the Retatrutide category Replied, post #4 · Compounds › Retatrutide · 10 Aug 2024 · 12 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
Guidelines revision: what changed and why Replied, post #7 · Meta › Announcements · 24 Jul 2024 · 0 likes Answering the question post #5 raises rather than the one it answers. If someone has run guidelines revision properly I would rather read that than my own…
Cold packs, phase-change material, and what survives ten days Replied, post #15 · Sourcing › Logistics · 15 Jun 2024 · 22 likes Reading rather than answering, but this is the post I would point somebody at.
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #12 · Practice › Dosing & titration · 12 Jun 2024 · 32 likes I had written a reply contradicting post #8 and deleted it. Here is what survived. Splitting a weekly dose in two: the pharmacokinetic argument against is that you want…